304 related articles for article (PubMed ID: 33941612)
1. Inhibition of Jumonji Histone Demethylases Selectively Suppresses HER2
Bhan A; Ansari KI; Chen MY; Jandial R
Cancer Res; 2021 Jun; 81(12):3200-3214. PubMed ID: 33941612
[TBL] [Abstract][Full Text] [Related]
2. Autocrine GMCSF Signaling Contributes to Growth of HER2
Ansari KI; Bhan A; Saotome M; Tyagi A; De Kumar B; Chen C; Takaku M; Jandial R
Cancer Res; 2021 Sep; 81(18):4723-4735. PubMed ID: 34247146
[TBL] [Abstract][Full Text] [Related]
3. A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth.
Wang L; Chang J; Varghese D; Dellinger M; Kumar S; Best AM; Ruiz J; Bruick R; Peña-Llopis S; Xu J; Babinski DJ; Frantz DE; Brekken RA; Quinn AM; Simeonov A; Easmon J; Martinez ED
Nat Commun; 2013; 4():2035. PubMed ID: 23792809
[TBL] [Abstract][Full Text] [Related]
4. HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.
Duru N; Fan M; Candas D; Menaa C; Liu HC; Nantajit D; Wen Y; Xiao K; Eldridge A; Chromy BA; Li S; Spitz DR; Lam KS; Wicha MS; Li JJ
Clin Cancer Res; 2012 Dec; 18(24):6634-47. PubMed ID: 23091114
[TBL] [Abstract][Full Text] [Related]
5. Disruption of the
Matthews KA; Senagbe KM; Nötzel C; Gonzales CA; Tong X; Rijo-Ferreira F; Bhanu NV; Miguel-Blanco C; Lafuente-Monasterio MJ; Garcia BA; Kafsack BFC; Martinez ED
ACS Infect Dis; 2020 May; 6(5):1058-1075. PubMed ID: 32272012
[TBL] [Abstract][Full Text] [Related]
6. Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM).
Lapidot M; Case AE; Weisberg EL; Meng C; Walker SR; Garg S; Ni W; Podar K; Hung YP; Carrasco RD; Knott A; Gokhale PC; Sharma S; Pozhitkov A; Kulkarni P; Frank DA; Salgia R; Griffin JD; Saladi SV; Bueno R; Sattler M
Br J Cancer; 2021 Aug; 125(4):582-592. PubMed ID: 34088988
[TBL] [Abstract][Full Text] [Related]
7. JIB-04, A Small Molecule Histone Demethylase Inhibitor, Selectively Targets Colorectal Cancer Stem Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway.
Kim MS; Cho HI; Yoon HJ; Ahn YH; Park EJ; Jin YH; Jang YK
Sci Rep; 2018 Apr; 8(1):6611. PubMed ID: 29700375
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.
Gupta P; Srivastava SK
BMC Med; 2012 Jul; 10():80. PubMed ID: 22824293
[TBL] [Abstract][Full Text] [Related]
9. JIB-04, a Pan-Inhibitor of Histone Demethylases, Targets Histone-Lysine-Demethylase-Dependent AKT Pathway, Leading to Cell Cycle Arrest and Inhibition of Cancer Stem-Like Cell Properties in Hepatocellular Carcinoma Cells.
Lee J; Kim JS; Cho HI; Jo SR; Jang YK
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887001
[TBL] [Abstract][Full Text] [Related]
10. The small molecule JIB-04 disrupts O
Cascella B; Lee SG; Singh S; Jez JM; Mirica LM
Chem Commun (Camb); 2017 Feb; 53(13):2174-2177. PubMed ID: 28144654
[TBL] [Abstract][Full Text] [Related]
11. Targeting the EphB4 receptor tyrosine kinase sensitizes HER2-positive breast cancer cells to Lapatinib.
Ding J; Yao Y; Huang G; Wang X; Yi J; Zhang N; Liu C; Wang K; Zhang Y; Wang M; Liu P; Ye M; Li M; Cheng H
Cancer Lett; 2020 Apr; 475():53-64. PubMed ID: 32006616
[TBL] [Abstract][Full Text] [Related]
12. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1.
Qiu MT; Fan Q; Zhu Z; Kwan SY; Chen L; Chen JH; Ying ZL; Zhou Y; Gu W; Wang LH; Cheng WW; Zeng J; Wan XP; Mok SC; Wong KK; Bao W
Oncotarget; 2015 Oct; 6(31):31702-20. PubMed ID: 26397136
[TBL] [Abstract][Full Text] [Related]
13. Fisetin inhibits proliferation of pancreatic adenocarcinoma by inducing DNA damage via RFXAP/KDM4A-dependent histone H3K36 demethylation.
Ding G; Xu X; Li D; Chen Y; Wang W; Ping D; Jia S; Cao L
Cell Death Dis; 2020 Oct; 11(10):893. PubMed ID: 33093461
[TBL] [Abstract][Full Text] [Related]
14. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
Menendez JA; Vellon L; Lupu R
Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
[TBL] [Abstract][Full Text] [Related]
15. Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors.
Dalvi MP; Wang L; Zhong R; Kollipara RK; Park H; Bayo J; Yenerall P; Zhou Y; Timmons BC; Rodriguez-Canales J; Behrens C; Mino B; Villalobos P; Parra ER; Suraokar M; Pataer A; Swisher SG; Kalhor N; Bhanu NV; Garcia BA; Heymach JV; Coombes K; Xie Y; Girard L; Gazdar AF; Kittler R; Wistuba II; Minna JD; Martinez ED
Cell Rep; 2017 May; 19(8):1669-1684. PubMed ID: 28538184
[TBL] [Abstract][Full Text] [Related]
16. Lysine demethylase KDM4A associates with translation machinery and regulates protein synthesis.
Van Rechem C; Black JC; Boukhali M; Aryee MJ; Gräslund S; Haas W; Benes CH; Whetstine JR
Cancer Discov; 2015 Mar; 5(3):255-63. PubMed ID: 25564516
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets.
Bayo J; Fiore EJ; Dominguez LM; Real A; Malvicini M; Rizzo M; Atorrasagasti C; García MG; Argemi J; Martinez ED; Mazzolini GD
J Hepatol; 2019 Jul; 71(1):78-90. PubMed ID: 30880225
[TBL] [Abstract][Full Text] [Related]
18. JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity.
Xun J; Wang D; Shen L; Gong J; Gao R; Du L; Chang A; Song X; Xiang R; Tan X
Oncotarget; 2017 Mar; 8(13):21918-21929. PubMed ID: 28423536
[TBL] [Abstract][Full Text] [Related]
19. HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib.
Valabrega G; Capellero S; Cavalloni G; Zaccarello G; Petrelli A; Migliardi G; Milani A; Peraldo-Neia C; Gammaitoni L; Sapino A; Pecchioni C; Moggio A; Giordano S; Aglietta M; Montemurro F
Breast Cancer Res Treat; 2011 Nov; 130(1):29-40. PubMed ID: 21153051
[TBL] [Abstract][Full Text] [Related]
20. Targeting P16INK4A in uterine serous carcinoma through inhibition of histone demethylation.
Xiao Z; He Y; Liu C; Xiang L; Yi J; Wang M; Shen T; Shen L; Xue Y; Shi H; Liu P
Oncol Rep; 2019 May; 41(5):2667-2678. PubMed ID: 30896884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
